OpenScholar

Search results

471 results found

Dolores Velit Soluta Nemo

Page

Impedit aliquid quas asperiores similique et. Dolores minus non qui deserunt. Sit Minima Eveniet Iusto Error. Quaerat eligendi occaecati nesciunt totam totam. Est ut commodi officiis. Dolor minus illo. Magnam eaque rerum suscipit sequi quae quisquam possimus. Rerum ipsum harum. Ea esse quis...

Contact Information

Page

Santosh Pothula, Ph.D.

he/him

Person: Research Scientist I

Xiaoman Liu, Ph.D.

she/her

Person: Research Scientist I

Sahana Natarajan

Person: Research Associate, (she/her)

Ankur Kumar

Person: Computational Associate II

I am interested in hacking biological systems for fun and profit. This includes (non-exhaustively) using tools from mathematics, computer science, and engineering disciplines to probe, understand, and program biological systems.

Seungmin "Sam" Hwang

Person: Principal Investigator

Seungmin “Sam” Hwang is a senior translation group leader within the Center for Integrated Solutions for Infectious Diseases ( CISID) at the Broad Institute of MIT and Harvard. Hwang joined the Broad Institute in September 2023, and the focus of his research is to elucidate the mechanisms of organ...

Caitlin OSullivan

Person: Research Associate I

Inaugural Merkin Prize in Biomedical Technology awarded to Dr. Marvin Caruthers for developing technology that efficiently synthesizes DNA

Page

CONTACT Sarah Farris sarah@comsint.com VIDEO Link The $400,000 award recognizes the far-reaching medical impact of Dr. Caruthers’ development, in the early 1980s, of an efficient and fast method to synthesize nucleic acids. Cambridge, MA (June XX, 2023)—Dr. Marvin H. Caruthers of the University of...

Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal

Publication: Journal Article

Krill‑Burger, Michael, Joshua M. Dempster, Ashir A. Borah, Brenton R. Paolella, David E. Root, Todd R. Golub, Jesse S. Boehm, et al. 2023. “Partial Gene Suppression Improves Identification of Cancer Vulnerabilities When CRISPR-Cas9 Knockout Is Pan-Lethal”. Genome Biol 24 (1).